WallStreetZenWallStreetZen

NASDAQ: ADMA
Adma Biologics Inc Stock Ownership - Who owns Adma Biologics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Adma Biologics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Kaitlin M. KestenbergmessinaCOO and SVP Compliance2024-03-312,085$6.60
$13.76kSell
Adam S. GrossmanPresidentCEO and Interim CFO2024-03-3121,752$6.60
$143.56kSell
Steve ElmsDirector2024-03-19411,829$6.08
$2.50MSell
Steve ElmsDirector2024-03-1849,887$6.01
$299.82kSell
Steve ElmsDirector2024-03-15183,008$6.01
$1.10MSell
Steve ElmsDirector2024-03-14448,276$6.05
$2.71MSell
Steve ElmsDirector2024-03-13407,000$6.21
$2.53MSell
Adam S. GrossmanPresident and CEO2024-03-0728,763$6.16
$177.18kSell
Brian LenzEVP CFO2024-03-0716,965$6.16
$104.50kSell
Adam S. GrossmanPresident and CEO2024-03-0655,003$6.12
$336.62kSell

1 of 5

ADMA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADMA insiders and whales buy or sell their stock.

ADMA Shareholders

What type of owners hold Adma Biologics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc7.85%17,917,745$117.18MInstitution
Perceptive Advisors LLC5.81%13,262,375$86.74MInsider
Vanguard Group Inc5.65%12,891,875$84.31MInstitution
Divestiture Trust Biotest5.65%12,886,740$84.28MInsider
Nuveen Asset Management LLC4.98%11,355,477$74.26MInstitution
Ag Biotest4.43%10,109,534$66.12MInsider
State Street Corp4.16%9,483,590$62.02MInstitution
Stonepine Capital Management LLC4.04%9,222,617$60.32MInstitution
American Century Companies Inc2.99%6,812,691$44.55MInstitution
D E Shaw Co Inc2.85%6,513,553$42.60MInstitution

1 of 3

ADMA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADMA74.12%24.57%Net SellingNet Selling
VCYT64.44%35.56%Net SellingNet Selling
ARDX38.01%61.99%Net SellingNet Selling
PTGX79.94%20.06%Net SellingNet Selling
EWTX84.23%15.77%Net BuyingNet Buying
View Top Biotech Stocks

Adma Biologics Stock Ownership FAQ

Who owns Adma Biologics?

Adma Biologics (NASDAQ: ADMA) is owned by 74.12% institutional shareholders, 24.57% Adma Biologics insiders, and 1.31% retail investors. Perceptive Advisors LLC is the largest individual Adma Biologics shareholder, owning 13.26M shares representing 5.81% of the company. Perceptive Advisors LLC's Adma Biologics shares are currently valued at $85.67M.

If you're new to stock investing, here's how to buy Adma Biologics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.